Filing Details
- Accession Number:
- 0001140361-11-002888
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-14 12:45:35
- Reporting Period:
- 2011-01-12
- Filing Date:
- 2011-01-14
- Accepted Time:
- 2011-01-14 12:45:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1107421 | Ziopharm Oncology Inc | ZIOP | Services-Specialty Outpatient Facilities, Nec (8093) | 841475642 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1091823 | J Randal Kirk | C/O Third Security, Llc 1881 Grove Avenue Radford VA 24141 | Yes | No | Yes | No | |
1356090 | Intrexon Corp | C/O Legal Department 20358 Seneca Meadows Parkway Germantown MD 20876 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-01-12 | 25,000 | $0.00 | 25,000 | No | 4 | A | Direct | |
Common Shares | Acquisiton | 2011-01-12 | 2,426,235 | $4.80 | 2,426,235 | No | 4 | P | Indirect | By Intrexon Corporation |
Common Stock | Acquisiton | 2011-01-12 | 3,636,926 | $0.00 | 6,063,161 | No | 4 | P | Indirect | By Intrexon Corporation |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | P | Indirect | By Intrexon Corporation |
No | 4 | P | Indirect | By Intrexon Corporation |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to Purchase Common Stock | Acquisiton | 2011-01-12 | 25,000 | $0.00 | 25,000 | $5.21 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,000 | 2021-01-12 | No | 4 | A | Direct |
Footnotes
- All restrictions related to the grant of restricted stock will lapse on January 12, 2012.
- Randal J. Kirk, directly and through certain affiliates, has voting and dispositive power over a majority of the outstanding capital stock of Intrexon Corporation. Mr. Kirk may therefore be deemed to have voting and dispositive power over the shares of the issuer owned by Intrexon Corporation. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
- Shares were issued as partial consideration in connection with the execution of an Exclusive Channel Partner Agreement dated January 6, 2011 between the issuer and Intrexon Corporation.
- Option to purchase shares of common stock will vest over a three (3) year period as follows: 8,334 shares on January 12, 2012; 8,333 shares on January 12, 2013; and 8,333 shares on January 12, 2014.